Another potential mechanism that can explain the higher thrombosis risk is that cancer cells can activate the endothelium through adherence to endothelial cells or by the production of proinflammatory cytokines, such as thrombomodulin I, tissue factor, von Willebrand factor, selectins, and fibrinolysis proteins (PAI-1) (16). Here, F3 is linked to cancer.